<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: cardinal</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cardinal'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22cardinal%22&t=%22cardinal%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:11:11 +0100</lastBuildDate>
        <item>
            <title>Should You Share Your Therapist With a Friend?</title>
            <link>http://www.medworm.com/index.php?rid=5062292&amp;cid=t_135550_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2011%2F07%2F25%2Fshould-you-share-your-therapist-with-a-friend%2F</link>
            <description>I have a friend who lives by this cardinal rule: She will never ever work with a friend. 
So when jobs surface in her company, or if she hears of an opening in her field, she only shares the information with non-friends. It’s just too messy, she explained to me the other day. 
Having experienced a situation not too long ago that became just that &amp;#8212; messy &amp;#8212; I can understand her logic and applaud her for sticking by that rule. I am now much more careful about sharing work opportunities with close friends&amp;#8230; in order to protect myself.
Should the same rule apply to therapy?

I never thought so. I mean, my psychiatrist told me the other day that I am her third biggest source of referrals, after a local cardiologist and a gynecologist. I don’t hesitate to share the numbers of...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5062292</comments>
            <pubDate>Mon, 25 Jul 2011 16:13:50 +0100</pubDate>
            <guid isPermaLink="false">5062292</guid>        </item>
        <item>
            <title>The Continuing Parade of Legal Settlements by Health Care Organizations: Cardinal, Cerberus, Dartmouth-Hitchcock, Masonicare</title>
            <link>http://www.medworm.com/index.php?rid=4775352&amp;cid=t_135550_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2011%2F05%2Fcontinuing-parade-of-legal-settlements.html</link>
            <description>Here is our latest round-up of the more colorful legal settlements made by some US health care organizations.Cardinal HealthCardinal Health is a pharmaceutical services company. Per the Kansas City Star:A pharmaceutical distributor has settled a federal anti-kickback lawsuit by agreeing, in part, to pay $760,000 to former Kansas City Chiefs player Dan Saleaumua and a consultant.That money is part of an $8 million settlement that Cardinal Health Inc. of Ohio agreed to pay the U.S. government to settle the lawsuit.The lawsuit alleged that Cardinal offered Saleaumua and consultant Kevin Rinne an illegal $440,000 kickback so it could supply prescription drugs to seven Kansas City area Medicine Shoppe pharmacies that Saleaumua owned at the time.Cerberus Capital Management/ Dyncorp/ Steward Heal...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4775352</comments>
            <pubDate>Mon, 02 May 2011 19:00:00 +0100</pubDate>
            <guid isPermaLink="false">4775352</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=4753973&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F6I6iFNkZiNw%2F</link>
            <description>Hello, everyone. Another shiny day is unfolding on the Pharmalot corporate campus, where we have successfully begun hustling the short people off to the local school house. As for us, we have a busy day planned since we will host a webinar later about pharma ad agencies and procurement issues (look here). Meanwhile, here are some tidbits to get you started. Hope today is a productive one and see you soon&amp;#8230;
Merck Hep C Drug Boosted Cure Rates In Trials: FDA (Bloomberg News)
Abbott Trilipix &amp;#038; Statin Combo Can Cause Heart Problems: FDA (Reuters)
Painkillers Make Antidepressants Less Effective: Study (The Globe &amp;#038; Mail)
Cardinal Health Pays $8M To Settle Kickback Claims (Kansas City Business Journal)
Mitsui Buys CMO Operations In China (Outsourcing Pharma) (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4753973</comments>
            <pubDate>Tue, 26 Apr 2011 12:03:01 +0100</pubDate>
            <guid isPermaLink="false">4753973</guid>        </item>
        <item>
            <title>Shadow a Physician Assistant the Right Way</title>
            <link>http://www.medworm.com/index.php?rid=4532588&amp;cid=t_135550_175_f&amp;fid=39258&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FInsidePaTraining%2F%7E3%2FzLrGTXxLnKs%2Fshadow-a-physician-assistant-the-right-way</link>
            <description>In recent posts, we&amp;#8217;ve talked about why you need to shadow a physician assistant, and how to find a physician assistant to shadow.  When it&amp;#8217;s time to actually make it happen, there is definitely a right way to go about it.  First, know the four Cardinal Rules. Cardinal Rules to Shadow A Physician Assistant: Be professional; first [...]Visit us at Inside PA Training - Becoming A Physician Assistant (Source: Inside PA Training)</description>
            <author>Inside PA Training</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4532588</comments>
            <pubDate>Mon, 28 Feb 2011 20:30:33 +0100</pubDate>
            <guid isPermaLink="false">4532588</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=4207505&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F4JmCOEReBiI%2F</link>
            <description>Welcome back, everyone. We hope you had a nice long weekend that was refreshing and relaxing. Now, though, the time has come to resume the routine - yes, those meetings and deadlines loom once again. So please join us for a much-needed cup of stimulation as we plow through the to-do list. And here is another invite: our Dec. 9 webinar on the FDA&amp;#8217;s Accelerated Approval program (see here). Meanwhile, here are a few tidbits to get you going. Have a great day&amp;#8230;
Glaxo Signs Deal With Russia&amp;#8217;s Binnopharm (The Moscow Times)
Ranbaxy May Start Selling Generic Aricept (Bloomberg News)
Cardinal Health Buys Chinese Drug Distributor (MarketWatch)
KV Pharma Given Extra Time To Pay Fines (St. Louis Business Journal)
EMA To Revise Guidance On GMP Tech Transfer To CMOs (OutsourcingPharma)
...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4207505</comments>
            <pubDate>Mon, 29 Nov 2010 12:57:59 +0100</pubDate>
            <guid isPermaLink="false">4207505</guid>        </item>
        <item>
            <title>Cardinal Health Settles, Novartis Settles</title>
            <link>http://www.medworm.com/index.php?rid=3298273&amp;cid=t_135550_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2010%2F02%2Fcardinal-health-settles-novartis.html</link>
            <description>And the march of settlements continues....As reported by the Tulsa (Oklahoma) World,A company that provides hospital pharmacy management services in Tulsa has agreed to pay $1 million in civil penalties for failing to account for large amounts of missing prescription drugs, the U.S. Attorney's Office in Tulsa announced Friday.Cardinal Health Pharmacy Services agreed to settle allegations with the federal prosecutors' office, which alleged that the company's two Tulsa pharmacies were negligent and violated several provisions of the Controlled Substances Act.An audit showed that nearly 400,000 dosage units of hydrocodone, a painkiller, and 234,000 units of alprazolam, an anti-anxiety drug, were unaccounted for at the Hillcrest Medical Center pharmacy from October 2005 through June 2007, acco...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3298273</comments>
            <pubDate>Mon, 22 Feb 2010 22:09:00 +0100</pubDate>
            <guid isPermaLink="false">3298273</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=3294809&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FPxiU-CUwnfE%2F</link>
            <description>Hello, everyone, and welcome back from the weekend. We hope your time was relaxing and you had a chance to enjoy. Now, the routine, of course, returns. What lies in store this week? We can only guess, but to prepare, we are brewing the required cup of stimulation. Grab one yourself. Meanwhile, here are a few items to help you get moving. Good luck&amp;#8230;
Icahn Wants Four Genzyme Board Seats (TheStreet)
USPTO Tentatively Rejects Plavix Patent (Dow Jones)
Cardinal Pays $1M Fine For Missing Drugs (Columbus Business First)
Novartis Wins FDA OK For Meningitis Vaccine (MarketWatch)
Anthera Tries IPO With No Sales Or Products (Bloomberg News)
FDA To Decide On Amgen Prolia By July (Reuters)
EU Rejects J&amp;#038;J Drug For Skin Infections (Associated Press)
Hologic Settles Patent Suit With J&amp;#038;J (R...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3294809</comments>
            <pubDate>Mon, 22 Feb 2010 12:41:25 +0100</pubDate>
            <guid isPermaLink="false">3294809</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=3056882&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FJB_ObJOoTjc%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
Jazz Pharmaceuticals hired Kathryn Falberg as senior vp and cfo;
NovaDigm Therapeutics named R. Gordon Douglas as chairman;
Pfizer named Adele Gulfo as US president of its primary care business;
Amarin hired Joe Zakrzewski as executive chairman;
Cardinal Health added Carrie Cox to its board of directors;
Catalent Pharma Solutions hired Paul Burns as vp of global sales;
Kfor...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3056882</comments>
            <pubDate>Fri, 04 Dec 2009 13:24:18 +0100</pubDate>
            <guid isPermaLink="false">3056882</guid>        </item>
        <item>
            <title>Down Syndrome Center for Adults</title>
            <link>http://www.medworm.com/index.php?rid=2745525&amp;cid=t_135550_111_f&amp;fid=36048&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2Ff4Jvq4b3k6E%2F</link>
            <description>Here&amp;#8217;s some positive news for loved ones with Down Syndrome. A new wellness center will be opened in Chesterfield, Missouri, that will be devoted especially to adults with Down Syndrome. The center will be named for St. Louis Cardinal Albert Pujols, who has a daughter with Down Syndrome.

The clinic will be the first of its kind in the state, and will focus exclusively on the lives of adults with Down Syndrome. The site is expected to attract many medical experts in Down Syndrome from all over the state. The center opens in November.
Image: sxc.hu.




	
	
	
	
	
	
	
	
	
	


Post from: Blisstree
Down Syndrome Center for Adults (Source: A Hearty Life)</description>
            <author>A Hearty Life</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2745525</comments>
            <pubDate>Sat, 29 Aug 2009 22:48:29 +0100</pubDate>
            <guid isPermaLink="false">2745525</guid>        </item>
        <item>
            <title>Cardinal Pays $34M For Violating Substances Act</title>
            <link>http://www.medworm.com/index.php?rid=1852739&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F410350224%2F</link>
            <description>The big distributor was charged with failing to report suspicious sales of hydrocodone, which is a violation under the Controlled Substances Act, despite repeated warnings, according to the US Drug Enforcement Agency. The med was later distributed to pharmacies that filled illegitimate prescriptions from rogue Internet pharmacies.
Drugmakers and distributors are required to monitor and report suspicious orders of controlled substances. But the DEA says Cardinal allowed the diversion of millions of dosage units of hydrocodone, which is the generic name of a prescription painkiller that is classified under federal narcotics law as a Schedule III controlled substance.
Cardinal&amp;#8217;s &amp;#8220;negligent conduct contributed to our nation&amp;#8217;s serious pharmaceutical abuse problem,&amp;#8221; Miche...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1852739</comments>
            <pubDate>Fri, 03 Oct 2008 15:12:17 +0100</pubDate>
            <guid isPermaLink="false">1852739</guid>        </item>
        <item>
            <title>Cardinal to Spin Off Medical Device Business</title>
            <link>http://www.medworm.com/index.php?rid=1837112&amp;cid=t_135550_113_f&amp;fid=34695&amp;url=http%3A%2F%2Fmedicalconnectivity.com%2F2008%2F09%2F29%2Fcardinal-to-spin-off-medical-device-business%2F</link>
            <description>According to Modern Healthcare&amp;#8217;s daily IT e-newsletter today, Cardinal Health announced it will, &amp;#8220;spin off its clinical and medical products business into a separate, publicly traded company.&amp;#8221;
In what looks like a tussle between Cardinal&amp;#8217;s traditional supply chain services business and the young upstart CTS (clinical technologies and services) the two groups have decided to go their own way. With the retirement of Cardinal chair and CEO, Kerry Clark, the two vice chairs, George Barrett for supply chain services and David Schlotterbeck for CTS, are going separate ways. Barrett will take Clark&amp;#8217;s position and Schlotterbeck will head the $4 billion global company to be headquartered in San Diego.
The new business&amp;#8217; offerings will include product lines in the ...</description>
            <author>Medical Connectivity Consulting</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1837112</comments>
            <pubDate>Mon, 29 Sep 2008 23:10:48 +0100</pubDate>
            <guid isPermaLink="false">1837112</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… What Economy?</title>
            <link>http://www.medworm.com/index.php?rid=1841250&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F406527891%2F</link>
            <description>The stock market plunge reminds Pharmalot of the following true story: As Chicken Little walks down Wall Street, he’s heard shouting ‘The Sky Is Falling!’ Right on cue, a wiseguy broker from Brooklyn opens his window and shouts, &amp;#8216;Sell Sky!&amp;#8217; &amp;#8230;Hang on, everyone. And try not to panic.
Covance Abandons Plan For Research Venture In China (NJ.com)
Cardinal Health To Spin Off Medical Products Unit (Yahoo/Reuters)
Will Lending Woes Hurt Roche Bid For Genentech? (The Financial Times) (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1841250</comments>
            <pubDate>Mon, 29 Sep 2008 19:22:44 +0100</pubDate>
            <guid isPermaLink="false">1841250</guid>        </item>
        <item>
            <title>Cardinal Fined For Shipping To Rogue Pharmacy</title>
            <link>http://www.medworm.com/index.php?rid=1631583&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F337125000%2F</link>
            <description>The big wholesaler has agreed to pay a fine of $105,000 to settle a charge by the Ohio State Board of Pharmacy that it failed to report increases in drug orders from a rogue pharmacist, The Columbus Dispatch reports. 
The fine relates to Cardinal Health&amp;#8217;s shipments of controlled substances to Caringwell Pharmacy in Dublin, Ohio, from November 2006 until March 2007. The board said Cardinal provided addictive drugs, including prescription painkillers and anxiety meds, the paper writes. 
The pharmacy board, which regulates drug sellers and distributors that do business in Ohio, closed Caringwell last year for illegally selling the meds over the Internet. The board investigated Cardinal for failing to report the pharmacy had significantly increased orders of controlled substances, as is ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631583</comments>
            <pubDate>Wed, 16 Jul 2008 14:38:23 +0100</pubDate>
            <guid isPermaLink="false">1631583</guid>        </item>
        <item>
            <title>Father Michael Pfleger Hammered by Chicago Cardinal Francis George</title>
            <link>http://www.medworm.com/index.php?rid=1480622&amp;cid=t_135550_125_f&amp;fid=34819&amp;url=http%3A%2F%2Fflapsblog.com%2F2008%2F05%2F30%2Ffather-michael-pfleger-hammered-by-chicago-cardinal-francis-george%2F</link>
            <description>Pope Benedict XVI addresses the bishops at the Basilica of the National Shrine of the Immaculate Conception in Washington on the first full day of his visit to the United States April 16, 2008. At right is Chicago&amp;#8217;s Cardinal Francis George, president of the U.S. Conference of Catholic Bishops. At left is the Vatican&amp;#8217;s secretary of state, Cardinal Tarcisio Bertone.
Cardinal Francis George of the Archdiocese of Chicago has HAMMERED Father Michael Pfleger of St. Sabina’s Catholic Church on the South Side of Chicago over his comments at Trinity United Church of Christ this past Sunday.
&amp;#8220;The Catholic Church does not endorse political candidates. Consequently, while a priest must speak to political issues that are also moral, he may not endorse candidates nor engage in partis...</description>
            <author>FullosseousFlap's Dental Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1480622</comments>
            <pubDate>Fri, 30 May 2008 18:36:39 +0100</pubDate>
            <guid isPermaLink="false">1480622</guid>        </item>
        <item>
            <title>HAIs &amp; Free Lunches in Healthcare - Cardinal Health's Chasing Zero Summit</title>
            <link>http://www.medworm.com/index.php?rid=1455483&amp;cid=t_135550_118_f&amp;fid=36984&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FHealthManagementRx%2F%7E3%2F283243854%2Fhais-free-lunches-in-healthcare.html</link>
            <description>Something I received in the mail yesterday revived a bit of hope that the US hospital industry may be - FINALLY - 'getting it.'Hiding amidst all the grocery sales circulars was a flyer from Cardinal Health about the Chasing Zero Summit (Washington DC, Sept. 8-10, 2008).Those of you who are following me on Twitter.com know I've been jetting around to quite a few conferences this spring. As I try to calculate ROI for these trips more effectively, I'm being increasingly selective about the shows I think will be productive.At first I was excited about Chasing Zero - it's in my old hometown of DC, so I can see friends, family and colleagues while I'm in the area.According to the invite: &quot;The Chasing Zero Summit is designed to stimulate discussion between the industry's key stakeholders - hospit...</description>
            <author>Health Management Rx</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455483</comments>
            <pubDate>Sun, 04 May 2008 09:57:00 +0100</pubDate>
            <guid isPermaLink="false">1455483</guid>        </item>
        <item>
            <title>Cardinal now have a Chief Compliance Officer</title>
            <link>http://www.medworm.com/index.php?rid=1314101&amp;cid=t_135550_150_f&amp;fid=34768&amp;url=http%3A%2F%2Fpharmagossip.blogspot.com%2F2008%2F03%2Fcardinal-now-have-chief-compliance.html</link>
            <description>Cardinal Health has hired as its chief compliance officer the man who put former Ohio congressman James Traficant behind bars. The move comes amid federal investigations into Cardinal's distribution of controlled substances.Craig S. Morford, 49, was appointed in August by President Bush to be the second-highest ranking official in the Department of Justice and has a background in prosecuting corruption and organized-crime cases in Ohio. Morford was the assistant U.S. attorney who led the corruption trial against Traficant, then a U.S. representative serving the Youngstown area who was sentenced to eight years in prison in 2002.Morford will leave his federal post and join Cardinal Health on May 5, the company said yesterday. He will oversee compliance with internal and external policies and...</description>
            <author>PharmaGossip</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1314101</comments>
            <pubDate>Wed, 19 Mar 2008 08:32:00 +0100</pubDate>
            <guid isPermaLink="false">1314101</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=1303459&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F251329033%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs being announced each month. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
Elusys Therapeutics named Robert Gundel vp of research;
Endo Pharmaceuticals hired David Holveck as ceo and president;
Mylan named Dick Markham non-executive chairman of the board;
Ovation named Chris Silber vp, clinical affairs;
Mylan&amp;#8217;s Matrix Labs named Jagdish Viswanath Dore as ceo and managing director;
Cardinal Health named Michael Kauf...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1303459</comments>
            <pubDate>Fri, 14 Mar 2008 11:04:03 +0100</pubDate>
            <guid isPermaLink="false">1303459</guid>        </item>
        <item>
            <title>Teva North America CEO Leaves For Cardinal</title>
            <link>http://www.medworm.com/index.php?rid=1142704&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F214520491%2F</link>
            <description>This seems to have caught Wall Street by surprsie. George Barrett was liked by investors and his departure is causing some analysts to wonder aloud whether the changover will be an issue. Barrett will be replaced by Bill Marth, who is currently ceo and president of Teva USA.
Barrett, meanwhile, is joining Cardinal Health, one of the big US drug wholsalers, as vice chairman and will also serve as ceo of Cardinal&amp;#8217;s health-care supply chain services sector, according to a statement. Barrett, 53, will remain with Teva through January to assist in the transition and Marth, 53, will assume the additional role of CEO of Teva North America immediately, Teva said in its own statement.
Teva stock fell more than 4 percent earlier on the news, while Cardinal shares were up.
 (more&amp;#8230;)
Share ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1142704</comments>
            <pubDate>Thu, 10 Jan 2008 17:41:44 +0100</pubDate>
            <guid isPermaLink="false">1142704</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… A News Round-Up</title>
            <link>http://www.medworm.com/index.php?rid=1079862&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F196740544%2F</link>
            <description>Before you head off to that next meeting, lunch appointment or coffee break, now may be a good time to catch up on events. Here are some of the latest&amp;#8230;.
The Drug Enforcement Administration has suspended Cardinal Health&amp;#8217;s license to distribute controlled substances from its Lakeland, Florida, distribution center, the second such suspension in about a week. In both cases - the other occurred in its Auburn, Washington, facility - the DEA says Cardinal failed to maintain effective controls in distributing to retail pharmacies, Reuters writes. The DEA cited the sale of hydrocodone to pharmacies that allegedly dispensed excessive amounts of the pain treatment, based on improper prescriptions from Internet pharmacy Web sites.
Merck will spend as much as $600 million developing medicin...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1079862</comments>
            <pubDate>Fri, 07 Dec 2007 17:20:33 +0100</pubDate>
            <guid isPermaLink="false">1079862</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… The Weekend Is Here</title>
            <link>http://www.medworm.com/index.php?rid=1063010&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F193247012%2F</link>
            <description>And so we turn our attention to other matters, such as raking leaves and spending time with our short people. We may even read a book. And you? Whatever your passion, we hope you enjoy the time. Meanwhile, here are a few items to help you stay abreast, even as other activities beckon&amp;#8230;
Amgen&amp;#8217;s Aranesp Data Disappoints (TheStreet.com)
Fosamax Users Seek Class-Action Lawsuit Status (Yahoo/AP)
King Pharma Options Up On Takeover Speculation (Yahoo/Reuters)
DEA Move May Not Hurt Cardinal Health (Yahoo/AP)
UK&amp;#8217;s NHS Calls For Redirecting Cancer Med Expenditures (BBC)
Share / E-mail (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1063010</comments>
            <pubDate>Sat, 01 Dec 2007 01:16:58 +0100</pubDate>
            <guid isPermaLink="false">1063010</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Take A Break</title>
            <link>http://www.medworm.com/index.php?rid=1005356&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F180186631%2F</link>
            <description>A busy, busy day today. But is anyone surprised? Not us. And so as we continue to pursue various lines of inquiry, we thought we would pause to pass along a few interesting items&amp;#8230;
Lilly And Daiichi Plan New Prasugrel Study (Yahoo/Reuters)
Cardinal Health Drug Distribution Unit Is Reeling (Bloomberg News)
WHO Tries To Balance Helping The Poor And Drugmakers (Associated Press)
Cytogen Hires Advisers To Explore Options (Yahoo/Reuters)
Share / E-mail (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1005356</comments>
            <pubDate>Mon, 05 Nov 2007 20:49:50 +0100</pubDate>
            <guid isPermaLink="false">1005356</guid>        </item>
        <item>
            <title>The Round Up: A Few Stray Items</title>
            <link>http://www.medworm.com/index.php?rid=972853&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F173825742%2F</link>
            <description>For many who have trouble falling or staying asleep, sleeping pills remain popular, but aren&amp;#8217;t terribly effective - they help you fall asleep and stay asleep a very modest amount, and cost a great deal, as The New York Times reminds us. Rozerem, for instance, gets you to sleep 7 to 16 minutes faster than a placebo, or fake pill; increases total sleep time 11 to 19 minutes, and costs $3.50 a pill, according to an analysis last year. “People seem to be getting a lot of relief from sleeping pills, but does getting 25 minutes of sleep really give you all that relief?” Wallace Mendelson, the former director of a sleep disorders unit at the University of Chicago and industry consultant, tells the paper. “A bigger aspect of this is that they change a person’s perception of their sta...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=972853</comments>
            <pubDate>Tue, 23 Oct 2007 13:59:34 +0100</pubDate>
            <guid isPermaLink="false">972853</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=904631&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F161496556%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Here are some of the latest moves…
Lilly names Lauren Marangell as a Distinguished Scholar;
Cardinal Health named ceo R. Kerry Clark as chairman;
Shire appointed Sylvie Gregoire as prez, human genetic therapies biz;
Cell Therapeutics adds Richard Love to its board;
MacroGenics named Jeff Buchalter as chairman;
Stiefel Labs appointed Lodewijk de Vink, to its board;
Keryx Biopharmaceuticals named Mike Tarnok to its board;
Gen-Probe named John Martin to its board;
CG Therapeutics appointed Chris Henney ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=904631</comments>
            <pubDate>Wed, 26 Sep 2007 11:29:25 +0100</pubDate>
            <guid isPermaLink="false">904631</guid>        </item>
        <item>
            <title>Up And Down The Ladder: Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=817762&amp;cid=t_135550_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F147329219%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don&amp;#8217;t be shy. Everyone wants to know who is coming and going. Here are some of the latest moves…
Cardinal Health named Vivek Jain exec vp of strategy and corporate development;
XTENT adds Mike Eagle, former Lilly manufacturing vp to its board;
Quintiles Transnational named Mike Troullis as cfo;
BioVex appointed Thaddeus Pullano vp of quality assurance;
Mediware Info Systems hired Noel Strong as chief tech officer and R&amp;#038;D vp;
AEterna Zentaris appointed Paul Blake sr vp and chief medical officer;
SpectraScience appointed Michel Vaudry as director of inte...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=817762</comments>
            <pubDate>Thu, 23 Aug 2007 11:44:54 +0100</pubDate>
            <guid isPermaLink="false">817762</guid>        </item>
        <item>
            <title>A Spot of Red</title>
            <link>http://www.medworm.com/index.php?rid=779994&amp;cid=t_135550_107_f&amp;fid=35762&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2Fscienceblogs%2Fgrrlscientist%2F%7E3%2F140699671%2Fa_spot_of_red.php</link>
            <description>tags: Northern cardinal, Cardinalis cardinalis, birds, Image of the Day






Male Northern cardinal, Cardinalis cardinalis, feeds his chick in Central Park, NYC. [song link]

I found this pair about twenty feet away from the nest site. I have been observing the progress of the nest and was delighted to find at least two of the three nestlings had fledged successfully. Should you find this inspirational I would hope you will demonstrate some restraint and not try it yourself at home with a significant other. I would strongly recommend you leave it to the professionals.


Image: Bob Levy [much larger]





 Read the comments on this post... (Source: Living the Scientific Life (Scientist, Interrupted))</description>
            <author>Living the Scientific Life (Scientist, Interrupted)</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=779994</comments>
            <pubDate>Sat, 04 Aug 2007 19:59:23 +0100</pubDate>
            <guid isPermaLink="false">779994</guid>        </item>
        <item>
            <title>HIV-2 Good For Share Price?</title>
            <link>http://www.medworm.com/index.php?rid=764755&amp;cid=t_135550_135_f&amp;fid=35272&amp;url=http%3A%2F%2Fslimconomy.blogspot.com%2F2007%2F07%2Fhiv-2-good-for-share-price.html</link>
            <description>How OraSure Leveraged HIV-2 To Drive Share Price &amp; VolumeIn 2003 in Illinois, two titans of the health care industry went to battle with the State Assembly. Compared to the raucous media battles over the intellectual property of ARV drug formulas, this was but a skirmish. But it was perhaps the first salvo in the coming battle for one company's determination to capture a market. OraSure leveraged the legal forces of Abbott, it's then main distributor, to lobby the State to make HIV-2 testing mandatory in Illinois. Chicago (actually Waukeegan, a small suburb north of Chicago) is home to both Abbott and Cardinal Health. It was Cardinal Health who would line up its legal forces in this opening skirmish.But testing for HIV-2 and HIV-1, that's good isn't it?For a small company with a product th...</description>
            <author>Slimconomy</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=764755</comments>
            <pubDate>Sun, 29 Jul 2007 00:56:00 +0100</pubDate>
            <guid isPermaLink="false">764755</guid>        </item>
    </channel>
</rss>

